Every Day Counts in the Race Against Cancer
Agilent is dedicated to pushing the boundaries of cancer research and diagnostics.
Our innovative solutions and strategic partnerships are at the forefront of transforming cancer care, enabling us to deliver comprehensive multiomic insights and cutting-edge diagnostic tools that empower researchers and clinicians to make more informed decisions and ultimately improve patient care. Whether your early discovery research, clinical trials or diagnostic tools development, Agilent is there to support scientists with an integrated portfolio of solutions.
AACR Agilent Media Event Presentation
Poster Presentations
New Product Introductions
BioTek Cytation 9 Cell Imaging Multimode Reader
-
The latest evolution of the Cytation portfolio, trusted for more than a decade as the industry standard for combined multimode microplate reading and high‑content cell imaging.
Discover how its significantly enhanced imaging optics and powerful new features enable walk‑away automation and expand your assay possibilities.
Learn more
Discover the next generation of hybrid analysis—advancing what’s possible in automated cell imaging and detection.
Visit Booth #4527 at AACR and be one of the first to learn more.
Exhibitor Spotlight Session
Direct Targeted Methylation Sequencing (dTMS) with SureSelect: targeted long-read sequencing for native variant and methylation profiling in oncology
Presented by: Andrew Jenkins, Biotechnology Research Associate, Wasatch Biolabs
Date: Monday, April 20, 2026
Time: 10:00 AM - 11:00 AM PST
Location: Theater D
xCELLigence Cancer & Immunotherapy Symposium
Learn more about the work being done by the incredible speakers listed below:
Super‑charged NK cells increase immune infiltration in the tumor microenvironment and inhibit tumor growth
Presented by: Dr. Kawaljit Kaur, CEO, ImmuneLink; Scientific Advisor on NK cells and/or cell‑based immunotherapies; Biotech Investor
The impact of microbial-derived metabolites on innate immune cell anti‑cancer activities
Presented by: Dr. Katherine Cook, Associate Professor, Wake Forest University
Strategies to overcome breast-to-brain metastasis
Presented by: Dr. David Soto-Pantoja, Associate Professor / Principal Investigator, Wake Forest University
Event Details:
Date: Saturday April 18, 2025
Time: 1:00 PM - 6:00 PM
Location: University of California San Diego Campus
Theatre District – Survivance 1126 conference room 11th floor of the Survivance Building
Ask a Question
To request more information about the press conference content or learn more about Agilent's cancer research solutions contact:
Agilent Public Relations
pdl-business-pr@agilent.com